Arcadia Common Stock Shares Outstanding from 2010 to 2024

RKDA Stock  USD 2.93  0.06  2.01%   
Arcadia Biosciences' Common Stock Shares Outstanding is increasing over the years with slightly volatile fluctuation. Overall, Common Stock Shares Outstanding is expected to go to about 1.3 M this year. Common Stock Shares Outstanding is the total number of shares of a company's common stock that are currently owned by all its shareholders. View All Fundamentals
 
Common Stock Shares Outstanding  
First Reported
2013-09-30
Previous Quarter
1.3 M
Current Value
1.4 M
Quarterly Volatility
3.9 M
 
Yuan Drop
 
Covid
Check Arcadia Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arcadia Biosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.6 M, Interest Expense of 247.1 K or Selling General Administrative of 14.7 M, as well as many indicators such as Price To Sales Ratio of 0.69, Dividend Yield of 0.0 or PTB Ratio of 0.32. Arcadia financial statements analysis is a perfect complement when working with Arcadia Biosciences Valuation or Volatility modules.
  
Check out the analysis of Arcadia Biosciences Correlation against competitors.
For information on how to trade Arcadia Stock refer to our How to Trade Arcadia Stock guide.

Latest Arcadia Biosciences' Common Stock Shares Outstanding Growth Pattern

Below is the plot of the Common Stock Shares Outstanding of Arcadia Biosciences over the last few years. It is the total number of shares of a company's common stock that are currently owned by all its shareholders. Arcadia Biosciences' Common Stock Shares Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Arcadia Biosciences' overall financial position and show how it may be relating to other accounts over time.
Common Stock Shares Outstanding10 Years Trend
Slightly volatile
   Common Stock Shares Outstanding   
       Timeline  

Arcadia Common Stock Shares Outstanding Regression Statistics

Arithmetic Mean301,259
Geometric Mean123,367
Coefficient Of Variation143.31
Mean Deviation328,277
Median55,458
Standard Deviation431,738
Sample Variance186.4B
Range1.3M
R-Value0.80
Mean Square Error72B
R-Squared0.64
Significance0.0003
Slope77,314
Total Sum of Squares2.6T

Arcadia Common Stock Shares Outstanding History

20241.3 M
20231.2 M
2022599.4 K
2021532 K
2020249 K
2019159.1 K
201894.2 K

About Arcadia Biosciences Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Arcadia Biosciences income statement, its balance sheet, and the statement of cash flows. Arcadia Biosciences investors use historical funamental indicators, such as Arcadia Biosciences's Common Stock Shares Outstanding, to determine how well the company is positioned to perform in the future. Although Arcadia Biosciences investors may use each financial statement separately, they are all related. The changes in Arcadia Biosciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Arcadia Biosciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Arcadia Biosciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Arcadia Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Common Stock Shares Outstanding1.2 M1.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Information and Resources on Investing in Arcadia Stock

When determining whether Arcadia Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Arcadia Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Arcadia Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Arcadia Biosciences Stock:
Check out the analysis of Arcadia Biosciences Correlation against competitors.
For information on how to trade Arcadia Stock refer to our How to Trade Arcadia Stock guide.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Agricultural Products & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arcadia Biosciences. If investors know Arcadia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arcadia Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.63)
Earnings Share
(1.77)
Revenue Per Share
3.932
Quarterly Revenue Growth
0.019
Return On Assets
(0.34)
The market value of Arcadia Biosciences is measured differently than its book value, which is the value of Arcadia that is recorded on the company's balance sheet. Investors also form their own opinion of Arcadia Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Arcadia Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arcadia Biosciences' market value can be influenced by many factors that don't directly affect Arcadia Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arcadia Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arcadia Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arcadia Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.